• SinglePoint CEO Greg Lambrecht enthusiastic about revenue potential for CBD products in light of recent U.S. legalization
• The company plans on diversifying its CBD market opportunities through both Amazon and its online store, www.SingleSeed.com
• Lambrecht notes that the company will be “going after” the CBD and cannabis market “very hard” in 2019

SinglePoint, Inc. (OTCQB: SING), a diversified holding company specializing in the acquisition of small- to mid-sized companies (with an emphasis on new technologies), urges investors to “not sleep on SinglePoint” in 2019 as it looks ahead at a potentially impressive year filled with expansion and revenue growth.

SinglePoint provides its investors the opportunity to invest in a wide range of assets, including payment processing, cannabis and blockchain technologies. Recently, SinglePoint CEO Greg Lambrecht was featured on MoneyTV with Donald Baillargeon to speak to the impact of federal CBD legalization in the United States.

When asked about how the federal legalization of hemp and CBD would impact his company, Lambrecht said (http://ibn.fm/nkCeM), “We’re so excited…we’re going to go after that market very hard. As you know, SinglePoint is now a fully reporting OTCQB company, so we have a lot of opportunities for investment and acquisitions in the CBD market.” Lambrecht indicated that the company would be aggressively pursuing new opportunities in the CBD industry to take advantage of the burgeoning cannabis industry.

SinglePoint has had a historic interest in the CBD market. Lambrecht noted, “In 2014, we were putting terminals in dispensaries and were shut down [by the federal government], but now that CBD is federally legal, that allows us to spend the dollars necessary to be a competitor in the CBD industry.” He continued, “We’ve already signed up for four of the biggest trade shows in the country, [and] we’re going to have our [CBD] rack package ready.”

Aside from trade shows, Lambrecht sees the recent federal legislation opening doors for corner stores in towns across the nation. He explained (http://ibn.fm/nkCeM), “We’re going to go really hard at retail and try to really dominate that market. Now your Walgreens, Circle Ks, [etc.] can put this product in their stores without worrying that the federal government will give them a fine.” Lambrecht added that his personal experience in placing products in retail would align with SinglePoint’s retail goals for 2019.

When asked specifically about the effect that CBD and hemp legalization would have on SinglePoint’s online store, www.Singleseed.com, Lambrecht spoke enthusiastically about the website’s untapped potential. “We’re really getting bombarded with investors right now, and we can take that money and increase our SEO marketing [putting] more products on our online site.” Lambrecht noted that the site currently has over 200 products and has been a huge success. In describing his plans for the company in 2019, Lambrecht said (http://ibn.fm/nkCeM) the company plans on “throwing a lot of money at [the website] as well as getting [its] products on Amazon.”

In closing, Lambrecht advised investors and potential clients (http://ibn.fm/nkCeM), “We expect to do extremely well in the market in 2019, so don’t sleep on SinglePoint.”

For more information, visit the company’s website at www.SinglePoint.com

• Supreme Cannabis receives conditional approval to list on Toronto Stock Exchange
• Its 7ACRES line voted 2018 Cannabis Brand Of The Year
• Expects to reach annual output capacity of 50,000 kg by middle of 2019
• Company plans to launch jointly-developed products with Khalifa Kush Enterprises

Another day… another milestone… The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) makes progress seem so easy. After a string of recent successes that include completion of 19 flowering rooms, clinching a deal with Khalifa Kush Enterprises and copping the 2018 Cannabis Brand of the Year Award, the company has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange (“TSXV”) and list its common shares on the TSX (http://ibn.fm/qipSf). Conditional approval from the TSX Listings Committee is the penultimate step to a full listing, which is formalized and confirmed at a public listing ceremony. Supreme Cannabis expects the TSX listing to broaden its investment appeal and improve its ability to execute 2019’s strategic imperatives. If the past is any guide to the future, Supreme will continue to deliver on its promises.

The uplisting announcement follows an array of achievements in 2018. In December, 7ACRES, a wholly owned subsidiary of Supreme Cannabis, was recognized as ‘Brand of the Year’ at the 2018 Canadian Cannabis Awards presented by Lift & Co. (TSXV: LIFT). The Canadian Cannabis Awards celebrate Canadian cannabis, distinguishing the people, companies and products that make it great. 7ACRES was selected by a panel of industry professionals from a variety of sectors in the cannabis space. The award recognizes the enormous effort behind creating a brand, strategy, culture, image and impact that resonates in the public consciousness (http://ibn.fm/2D9l2).

7ACRES generated the sixth-highest revenue among Canadian licensed cannabis producers in the fourth quarter of 2018. Considering that 2018 was its first year of sales, the volume achieved validates Supreme’s strategy of producing high-end cannabis to scale. 7ACRES was able to complete 19 flowering rooms; it expects to achieve its target of 25 completed flowering rooms by March 2019. At that point, the total facility will extend over 440,000 square feet, with cultivation space of 300,000 square feet – about seven acres.

Supreme Cannabis expects 7ACRES to reach its estimated annual output of 50,000 kg by the middle of calendar 2019. During the year, the company aims to strengthen 7ACRES’ market position as a leading premium flower brand. It also has a number of other initiatives in the works.

Supreme has announced an exclusive consulting agreement with Wiz Khalifa’s Khalifa Kush Enterprises (KKE) to develop and launch a line of premium cannabis products in the budding Canadian market (http://ibn.fm/tpR7u). The move could bring the KKE strains that have proved so successful in the U.S. market into Canada’s emerging recreational market. Wiz Khalifa is a Grammy Award-winning American rapper, singer, songwriter and actor who has become an icon within the cannabis community. After collaborating with Colorado-based RiverRock Cannabis in 2016, Khalifa developed his own line of regulated marijuana strains, products and concentrates under the Khalifa Kush brand. These products have already hit dispensary shelves across most states where cannabis has been legalized.

Supreme has also acquired a 10 percent stake in Medigrow Lesotho (PTY) Limited (http://ibn.fm/5bo9U). In addition, the two companies have agreed to enter into a long-term global distribution partnership for medical cannabis oil (as defined in the Access to Cannabis for Medical Purposes Regulations). The cannabis oil will be produced by Medigrow in Lesotho, and, subject to all government and international regulatory approvals, the oil will be exported to international markets in the European Union and South America. Medigrow is located in the Kingdom of Lesotho in southern Africa. The company is licensed by the Lesotho Ministry of Health to cultivate and manufacture medical cannabis and cannabis oil products.

For more information, visit the company’s website at www.Supreme.ca

• DVLP offers business services and/or products supporting the cannabis sector
• The company’s strategy also includes acquisitions of compliant cannabis companies
• DVLP recently launched WheresCBD.com

A development-stage company, Golden Developing Solutions, Inc. (OTC: DVLP) is an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace. The company provides business services and/or products supporting the cannabis industry. These include an online retail business for cannabidiol, hemp oil and health/wellness-related products. DVLP has its corporate office in Austin, Texas.

In addition, the company’s strategy includes acquisitions of compliant cannabis companies according to state and federal laws (http://ibn.fm/ECUWp), as well as joint ventures. DVLP currently has a joint venture with Pura Vida Vitamins, LLC. Pura Vida merchandise includes hemp and cannabidiol-related products and other products focusing on health and lifestyle. Pura Vida’s premier product lineup includes traditional vitamins, supplements and cannabidiol-based tinctures, vapes and soft gels. Its direct-to-consumer website is www.PuraVidaVitamins.com.

As the demand for cannabis and related cannabidiol products increases worldwide, DVLP is positioning itself to capitalize on this significant opportunity. According to Business Wire (http://ibn.fm/jvhx2), “The global legal cannabis market research report by Technavio predicts the market to post a CAGR of more than 27% during the period 2019-2023.”

DVLP has also purchased the assets of Layer Six Media, Inc., including its flagship application, WheresWeed.com. A cannabis technology enterprise, Where’s Weed connects medical and recreational cannabis users with trusted local marijuana businesses in their respective communities. Where’s Weed offers an app that enables cannabis users to find local businesses with the best deals. Users can then promptly connect with others to share these deals.

DVLP has also created a new website (www.GreenerGrows.org) that permits cannabis growers of all kinds to obtain first-rate information and communicate with one another. GreenerGrows features actual industry metrics from real cannabis businesses. Businesses can anonymously share their metrics and compare them with others in their industry. With its safe and secure tools, GreenerGrows allows users to analyze their business data in order to make important operating decisions.

DVLP recently expanded its hemp-related products strategy with the launch of WheresCBD.com. For consumers looking for high-end hemp oil and cannabidiol isolates, the new site will gather together information on nationwide cannabidiol products (http://ibn.fm/0E74M). WheresCBD.com will be populated by the most popular cannabidiol products. These products include gummy bears and the leading cannabidiol oils. With the signing of the 2018 Farm Bill legalizing hemp, the door is open nationwide for DVLP, as the legislation permits states to regulate hemp production, commerce and research with approval from the USDA (http://ibn.fm/2uhZV).

In a news release, Stavros Triant, DVLP’s chief executive officer, said, “Where’s Weed has been a home run for us since we made the move and acquired the leading cannabis and hemp community hub several months ago. We outlined our strategy to invest in cannabis and hemp related services because we believed it was a tremendously undervalued space in terms of online real estate. The development of WheresCBD.com is a natural step in the same direction. Naturally, the signing of the 2018 Farm Bill will only serve to further bolster that momentum. Look for the launch to hit next quarter.”

With its two-pronged business strategy spanning cannabidiol and ancillary software, DVLP offers two channels for ROI for investors. Furthermore, with its intent to make more acquisitions in the near future, the company continues to stay ahead of the curve in its industry. DVLP’s commitment is to leading cannabis culture into the contemporary world.

For more information, visit the company’s website at www.GoldenDeveloping.com

• Shoppers Drug Mart, Canada’s largest pharmacy chain, will serve as the exclusive direct-to-patient online outlet for Flowr’s premium medical cannabis
• Flowr previously set a standard with Hawthorne Gardening and Holigen Ltd. partnerships
• Flowr’s high-yield growth expertise and premium product focus are expected to serve it well during anticipated cannabis supply glut and associated price drop

Premium cannabis cultivator The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) and Shoppers Drug Mart, Canada’s largest retail pharmacy chain, recently announced a multi-year deal for Flowr to supply medical cannabis for Shoppers’ new online cannabis store. Shoppers’ e-commerce website will also be the exclusive direct-to-patient online provider of the company’s FlowrRx-branded products.

“We believe that partnering with Shoppers Drug Mart to provide patients with premium medical cannabis is a game-changing opportunity for Flowr’s medical business and we look forward to working with their team,” Flowr Co-CEO Tom Flow stated in a January 9 news release about the agreement (http://ibn.fm/Pv4Ec). “FlowrRx products are grown in facilities designed to pharmaceutical industry manufacturing standards and using strict processes that should enable us to provide patients with both the high quality they seek and the consistent benefits they need.”

Shoppers has about 1,300 pharmacist-owned locations from coast to coast. At this time, however, the FlowrRx products will be sold exclusively online through the e-commerce site, since Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.

Flowr’s products are grown in British Columbia’s renowned Okanagan Valley, using proprietary cultivation systems engineered to Good Manufacturing Practices (GMP) standards that allow the company to consistently generate premium, non-irradiated product at high yields. Despite the supply-line difficulties that Canada’s cannabis industry has experienced in the months since adult-use legalization last fall, analysts predict that there will soon be an oversupply of cannabis product, and that such a trend will work in Flowr’s favor.

A December report by investment advice website The Motley Fool noted that, in a low-price market, the hardiest companies are those that have low operating costs, and the key to low operating costs in the cannabis industry is to have high yields per square foot (http://ibn.fm/qFgz3).

“Flowr beats most of the major Canadian marijuana producers when it comes to crop yield,” the report states. “Its expected yield in the coming year translates to a cost per gram of 2.05 in Canadian dollars, well below Canopy Growth’s and Tilray’s cost per gram. Even better, Flowr thinks it can increase its yield and lower costs even more.”

The company’s emphasis on premium and ultra-premium products also puts it among a select group that employs rigorous standards to deliver a stand-out product that’s likely to draw discerning consumers. Its potential attracted Scotts Miracle-Gro subsidiary Hawthorne Gardening, which entered into a research-and-development partnership with the company in March 2018 and broke ground on North America’s first research and development facility dedicated to advancing cannabis cultivation techniques and systems in October (http://ibn.fm/dGwZd).

The Hawthorne Gardening partnership made Flowr one of only three Canadian cannabis companies with a business partnership with a publicly traded U.S. company at the time.

“We chose to work with Flowr due to their ability to grow quality, consistent plants,” Hawthorne Gardening Senior Vice President and General Manager Chris Hagedorn stated in announcing the groundbreaking partnership. “Dedicated to innovation, this first-of-its-kind research facility will help to optimize our entire array of products, from lighting to nutrients and environmental controls, and put us in the unique position to help our customers, no matter their size and scale, get the result they seek with even more precision.”

In addition, the December announcement that Flowr had acquired a 19.8 percent share of Holigen Ltd., and signed an intellectual property sharing agreement with the international medical cannabis license-holding company, further portends the company’s potential beyond Canada’s borders (http://ibn.fm/qEvvj).

For more information, visit the company’s website at www.Flowr.ca

• QMC is quickly advancing toward completion of a NI 43-101 report
• The company expects the NI 43-101 report to test historically reported 1.2 million tons of 1.51 percent Li2O
• Lithium-ion battery forecasts support expectations that electric vehicles will overtake fossil fuel cars and exponentially boost demand for lithium

As a new year dawns, QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is positioning itself to “reawaken the promise in Manitoba’s historically rich lithium properties” by establishing the commercial lithium-bearing potential of the company’s Irgon Lithium Mine Project for the North American market (http://ibn.fm/ejCMw) and advancing its project toward mining production.

Lithium has occupied the green tech spotlight as a mineral that’s critical to the operation of the lithium-ion batteries that power a wide array of increasingly ubiquitous computer products, including cell phones, laptops and smart watches. The expected ascendance of the electric vehicle industry is adding exclamation marks because of its potential to exponentially increase lithium demand.

While lithium prices have been in decline recently, market analysts have debated the trend’s portent for the future, with many arguing that stock prices are overreacting and that prices should begin to rise again by the beginning of the coming decade. Seeking Alpha’s most recent monthly mining news edition also cited a report that Chinese company Envision Energy’s CEO is predicting that the price of electric vehicle batteries will drop so dramatically that they will “end the reign of the internal-combustion engine” and cause fossil fuel car production to disappear virtually “overnight” as EV prices become cheaper during the next few years (http://ibn.fm/c6EH4).

QMC’s efforts to supply a domestic source of lithium have focused on previously explored but underdeveloped hard rock mineral sites in southern Canada. Historically, North America’s hard rock miners dominated the lithium industry until the 1980s by extracting the white metal from the mineral spodumene, which, as a lithium aluminum inosilicate, is a source of lithium and is often found in large quantities. South American nations hosting the famed “Lithium Triangle” gained market dominance with their more economical lithium brine evaporation ponds as the price of the white metal fell, but companies such as QMC assert that the hard rock mining process is ultimately more reliable and faster to bring into production once the initial exploratory work has been completed.

QMC has invested over two years into its vision for its Manitoba property, known as the Irgon Lithium Mine Project, stating that, typically, hard rock projects take three to five years to commence production. The company is anticipating the completion of an updated NI 43-101 resource report on the Irgon Project, in which it holds a 100 percent undivided interest.

Irgon and several other known pegmatite dikes which host spodumene mineralization are located within the Irgon Property. The total project area encompassed by the 22 claims that comprise the Irgon Mine Project is 11,325 acres. Prior historical exploration at the site produced a resource estimate of 1.2 million tons of Li2O grading 1.51 percent over a strike length of 365 meters and to a depth of 213 meters. QMC expects that its pending resource estimate will identify higher grades, tonnages and strike distances of the dikes than those indicated by the original, historical resource report as a result of the very positive results from the company’s ongoing exploration program.

For more information, visit the company’s website at www.QMCMinerals.com

• Net Element specializes in mobile payments and value-added transactional services
• It provides an array of electronic payment solutions through numerous operating companies
• The company recently launched its blockchain-powered payments application

Investors looking to leverage opportunities in mobile payments and value-added transactional services need look no further than Net Element, Inc. (NASDAQ: NETE). The company specializes in these services and is strategically positioned for growth in the U.S. and emerging nations. An international technology-driven group, Net Element supports electronic payments acceptance in an omni-channel environment encompassing point-of-sale, e-commerce and mobile devices. Net Element is headquartered in North Miami Beach, Florida.

The company provides a host of electronic payment solutions via several operating companies. These include Aptito (its cloud-based restaurant and retail point-of-sale solution), Unified Payments, PayOnline, Digital Provider, Restoactive, Net Lab and SalesCentral (http://ibn.fm/gPg3C). Through these companies, Net Element’s strategy focuses on three areas of omni-channel processing – mobile payments direct carrier billing, point-of-sale solutions and payment acceptance value-added transactions.

Recently, Net Element launched a multi-channel, blockchain-powered payments acceptance application as an element of its Netevia Platform (www.Netevia.com). Netevia is a feature-ready multi-channel payments platform. It connects and streamlines payments through a single integration point. It does so while boosting the economic efficiency of all transactions made within the network. The Netevia platform supports Poynt and PAX smart payment terminals, e-commerce and in-app or online payment forms that join credit card and cryptocurrency payment methods in one simplified interface.

Utilizing Netevia’s user-friendly developer center, developers can create cryptocurrency acceptance functions to fit their requirements. Developers can also use Netevia’s API (Application Programming Interface) payment mechanism to add these functions. Therefore, broader acceptance and the widespread use of the Netevia platform offers investors an early-in opportunity to grow with Net Element.

Net Element has launched its blockchain-powered payments application across manifold outlets (http://ibn.fm/rqdGa). These touch points include face-to-face by way of smart payment terminals and electronic commerce, as well as through API. The cryptocurrency payment acceptance application is fully compliant and secure.

In a news release, Vlad Sadovskiy, Net Element’s president of integrated payments, said, “Over the past few years blockchain technology has revolutionized the world of payments thanks to its decentralization, cost-effectiveness and convenience. The addition of a cryptocurrency payment acceptance option to our Netevia platform carries forward our tradition of innovation as we power global commerce.”

With a mission of enabling its clients to conduct business worldwide, Net Element offers small to medium enterprises (SMEs) a unique mobile payments and value-added transactional services platform. For investors, the company offers growth opportunities as it works to increase transactional revenue by innovating SME productivity services through the use of diverse technology solutions and Aptito. Net Element is dynamically transforming its industry as it builds smarter point-of-sale options and delivers secure and scalable solutions.

For more information, visit the company’s website at www.NetElement.com

• CIIX recently hired Boustead Securities LLC as underwriter for the planned IPO of its wholly owned subsidiary, CBD Biotech
• Warren Wang, CEO of CIIX, said that the move is part of its strategic plan, as CIIX looks to return to its root activities in education and consulting with companies seeking to raise profile within the investment community
• Boustead Securities would serve as IPO sponsor and underwriter, CIIX said

ChineseInvestors.com, Inc.’s (OTCQB: CIIX) retention of Boustead Securities LLC for its anticipated IPO of wholly owned foreign enterprise CBD Biotech will enable the company to focus on its revenue base in video and online education, investor relations services and subscription activities. At the same time, CIIX plans to secure a separate exchange listing for CBD Biotech (http://ibn.fm/aS1BM).

In a news release, Warren Wang, CEO of CIIX, said, “Additionally, we believe that listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy.”

Dan McClory, Boustead Securities’ managing director, head of China and head of equity capital markets, was optimistic. “We believe CBD Biotech can potentially gain a first mover advantage in the Chinese CBD market and could be well received in the public markets,” he noted in a news release.

CIIX sees CBD Biotech delivering higher CBD product distribution in FY2019, both domestically and in China. It reported an 800 percent increase in product sales led by ChineseHempOil.com, Inc. during its fiscal first quarter of 2019. CIIX recorded 70 percent higher YOY sales for the same fiscal quarter (http://ibn.fm/cGO9x).

For more information, visit the company’s website at www.ChineseInvestors.com

• Canada’s “green rush” cannabis market challenges have revealed the importance of securing product pipeline
• Icon Exploration’s pending reverse takeover of LP applicant City View Green positions it to acquire 40,000-square-foot cultivation facility
• City View Green also holds option on additional 125,000 square feet of farm and extraction space for its planned edibles, distillates and water-soluble brands

As investors and consumers alike assess the gains and losses evident during the “green rush” of 2018, when companies such as Icon Exploration Inc. (TSX.V: IEX.H) launched aggressive efforts to capitalize on changing laws and attitudes regarding cannabis, their attention is turning toward companies that can deliver revenues by ensuring a steady product pipeline (http://ibn.fm/oA42R). Icon Exploration’s efforts to create a well-diversified company focused on becoming a leading purveyor of medicinal and recreational cannabis is evidence that the company’s industry-experienced team is preparing to meet that demand.

Icon Exploration is building its portfolio with a reverse takeover of private company City View Green, an applicant for Canada’s licensed producer designation that expects to complete a 40,000-square-foot cultivation facility near Toronto for pharmaceutical-grade cannabis once the government green lights the application. Another 4.3 acres at the location is being held for possible exponential upscaling with an additional 125,000 square feet of farm and extraction facilities.

City View Green intends to use the space for cultivating its cannabis and then producing high-quality edible products, distillates and water-soluble brands for the cannabidiol (CBD)-infused beverage market, a rising sector within the industry as consumers continue to explore non-smoking ways of benefiting from cannabis’ properties.

“We’re now realizing that it isn’t only about crop yield. Over the long term, it’s about lowering production costs and developing efficient extraction and processing methodologies,” CEO Rob Fia stated in an interview with Postmedia Content Works last year (http://ibn.fm/R3ARp). “It’s also about developing consumer products focused on the retail market, because the higher margins and potential will be there, not in flower. We’re particularly strong on beverages and cosmetics derived from cannabis, infused with either CBD or THC (tetrahydrocannabinol).”

In a new show of faith in Icon Exploration’s potential, Fia updated the company’s August early warning report to note that he has recently been issued 312,500 additional common shares of Icon at a price of $0.15 per share pursuant to the exercise of share purchase warrants (http://ibn.fm/FZwhH).

The update states that Fia now has ownership and control of more than 4.6 million shares of Icon. Despite the increase in the number of his shares in the company, the report states that dilution since August 2017 has decreased his overall ownership interest from about 16.1 percent to approximately 13.9 percent of Icon’s present outstanding shares, on a non-diluted basis. On a partially diluted basis in which the exercise of all 1.3 million-plus stock options held by Fia is assumed, he would have ownership and control over about 17.3 percent of the then-issued Icon shares.

City View Green expects to employ contractors and use about half of the planned Ontario facility’s space for growing product with state-of-the-art LED lighting, HVAC systems and automation technologies designed to ensure cannabis product consistency and quality. About 4,000 square feet will be devoted to an extraction laboratory outfitted for an ultra-efficient CO2 supercritical extraction process.

City View Green is also working with other companies in the cannabis sector to establish agreements for the supply of its products once the operation gets final approval from the government.

For more information, visit the company’s website at www.IconExploration.net

• eSignature Guarantee’s platform provides an easy online method for securities holders to receive medallion signature guarantee stamps for securities transfer
• eSignature Guarantee focuses on identity verification and fraud protection
• eSignature Guarantee is the only medallion stamp provider that permits identity verification online

eSignature Guarantee is an innovative, patent-pending online platform founded by Seth Farbman, Yoel Goldfeder and Moshe Joshua. This online platform enables stockholders to obtain a signature guarantee for the transfer of securities. In addition, the platform offers the ability to sign documents with a digital signature and upload them to eSignature.

A signature guarantee is a type of authentication provided by financial institutions. This is to prevent fraud, hasten the legal transfer of securities and protect transfer agents from the legal consequences of a fraudulent signature. Essentially, a signature guarantee authenticates the signature of a person making a request to transfer physical certificates of financial instruments such as securities.

Of note is that eSignature Guarantee is the only medallion stamp provider that permits the verification of identity online. The company’s emphasis is on identity verification and fraud protection. Its platform is a combination of state-of-the-art technology with an advanced intelligence identification verification system, so individuals can prove who they are.

eSignature Guarantee offers an easy, seamless process. The first step is identity confirmation. A user simply creates an account, then proceeds with the verification process. This involves providing his or her name, address, mobile phone number, social security number and birth date to verify identity. Confirmation codes are subsequently sent to the user’s email and mobile phone, and these codes are then entered into the correct field on screen.

Upon mobile number and email address confirmation, eSignature Guarantee’s advanced intelligence engine asks a series of multiple choice questions known only to the individual. Passing the dual-verification process and having the user’s identity verified is contingent on answering the questions correctly. This stringent security process protects the individual from identity theft.

The second step in the process involves providing securities details (ownership type, type of security, etc.). Information is taken regarding the specific securities that require stamps. The individual provides supporting documentation (stock power agreements or statement of ownership), selects a shipping method and pays for the service.

eSignature Guarantee makes the process as convenient as possible via varied options. Users can upload the documents, ship them to eSignature’s offices or use a combination of the two. If uploading documents, individuals can use the company’s digital signature tools.

The checkout page is the third step in the process, after all transaction information has been entered. A confirmation code is sent to the user’s mobile phone. This code is required before entering credit card payment information. As simple as that, the transaction is complete and eSignature Guarantee will stamp and ship the securities certificates upon receiving all the supporting information.

Regarding its electronic signature offering, eSignature Guarantee works with industry leader HelloSign to provide the highest level of comfort, technology and security. Moreover, it also provides an audit trail. Of great benefit is that all HelloSign fees are covered by eSignature.

eSignature Guarantee concentrates on making the transfer of securities an uncomplicated and efficient process. Its expert staff takes users step-by-step through the identification process and diligently reviews files to expedite transfers. eSignature’s platform melds compliance and technology in tandem with an exceptional level of client service to make obtaining a medallion stamp hassle-free.

For more information, visit the company’s website at www.eSignatureGuarantee.com

• Lexaria Bioscience has its innovative DehydraTECH drug delivery platform
• The company’s DehydraTECH technology is complementary to other R&D being done on cannabinoids
• Lexaria recently attended O’Cannabiz 2018 in Vancouver

A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the oral delivery of all cannabinoids.

The DehydraTECH drug delivery platform encapsulates cannabinoid compounds in a lipid molecule to eliminate undesirable tastes in cannabinoid edibles. Moreover, this improves bioavailability by protecting the cannabinoid compounds from stomach and first-pass liver metabolism (http://ibn.fm/tyvvj). The technology promotes lower overall dosing and higher effectiveness of lipophilic active molecules.

Recently, Lexaria Bioscience Chief Executive Officer Chris Bunka discussed company progress and plans at O’Cannabiz 2018 (http://ibn.fm/5uF6B). The O’Cannabiz Conference and Expo took place in Vancouver, British Columbia, in December 2018. The conference featured hundreds of international cannabis companies. Bunka noted (http://ibn.fm/ziUJo) that, in a nutshell, Lexaria makes, “…cannabis products taste better, smell better, and get into your bloodstream a lot more quickly.”

Lexaria Bioscience has provided these benefits to tea and other products. The company removes unwanted tastes as well as smells. Therefore, there is no need to add a lot of sugars or artificial ingredients to mask unpleasant flavors. Lexaria’s tea products sell as ViPova branded premium teas. The company’s other products include TurboCBD high-absorption, full spectrum hemp oil capsules.

Bunka further noted that Lexaria Bioscience has 10 patents granted with over 50 patents pending. Four of the granted patents focus on the delivery of nicotine. The company is not partnering with the tobacco industry. However, Bunka informed that Lexaria is exploring the potential use of its DehydraTECH technology to help people stop smoking.

The company’s technology has been shown to deliver nicotine to the brain quicker than traditional delivery systems. The goal for Lexaria is to put nicotine into some type of oral form to eliminate the need for inhalation and help people curb their smoking habits. DehydraTECH studies in 2018 included two animal studies that delivered pioneering results highlighting the improvements of nicotine delivery to blood plasma and across the blood-brain barrier (http://ibn.fm/QOjnR).

Lexaria Bioscience’s technology is patent protected for cannabidiol and all other non-psychoactive cannabinoids. The company has patents pending for THC, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine, other psychoactive cannabinoids and other molecules. An enabling technology and not a competing one, DehydraTECH is a complementary layer that works with the other research and development (R&D) being done on cannabinoids.

Lexaria Bioscience is on the move in its industry. The company is hiring new personnel and building a new laboratory in Canada. It recently created four new subsidiaries, which it is staffing up as well. With more growth on the horizon, Lexaria offers potential profit opportunities to investors wanting to leverage the company’s innovative DehydraTECH drug delivery platform.

For more information, visit the company’s website at www.LexariaBioscience.com